DNA Biomed (Israel) Market Value
| DNA Stock | ILS 88.60 1.60 1.84% |
| Symbol | DNA |
DNA Biomed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DNA Biomed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DNA Biomed.
| 02/29/2024 |
| 11/25/2024 |
If you would invest 0.00 in DNA Biomed on February 29, 2024 and sell it all today you would earn a total of 0.00 from holding DNA Biomed Solns or generate 0.0% return on investment in DNA Biomed over 270 days. DNA Biomed is related to or competes with Amot Investments, Skyline Investments, Alrov Properties, Hiron Trade, YD More, and One Software. D.N.A Biomedical Solutions Ltd. develops and commercializes laser spectrometry-based trace detection systems in Israel More
DNA Biomed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DNA Biomed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DNA Biomed Solns upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.56 | |||
| Information Ratio | 0.0576 | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (4.91) | |||
| Potential Upside | 9.28 |
DNA Biomed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for DNA Biomed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DNA Biomed's standard deviation. In reality, there are many statistical measures that can use DNA Biomed historical prices to predict the future DNA Biomed's volatility.| Risk Adjusted Performance | 0.0744 | |||
| Jensen Alpha | 0.2896 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0739 | |||
| Treynor Ratio | 0.4906 |
DNA Biomed Solns Backtested Returns
DNA Biomed appears to be very steady, given 3 months investment horizon. DNA Biomed Solns retains Efficiency (Sharpe Ratio) of 0.14, which denotes the company had a 0.14% return per unit of risk over the last 3 months. By reviewing DNA Biomed's technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please utilize DNA Biomed's Market Risk Adjusted Performance of 0.5006, downside deviation of 3.56, and Coefficient Of Variation of 1161.06 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, DNA Biomed holds a performance score of 10. The firm owns a Beta (Systematic Risk) of 0.78, which means possible diversification benefits within a given portfolio. As returns on the market increase, DNA Biomed's returns are expected to increase less than the market. However, during the bear market, the loss of holding DNA Biomed is expected to be smaller as well. Please check DNA Biomed's semi deviation, sortino ratio, semi variance, as well as the relationship between the standard deviation and value at risk , to make a quick decision on whether DNA Biomed's current price history will revert.
Auto-correlation | -0.07 |
Very weak reverse predictability
DNA Biomed Solns has very weak reverse predictability. Overlapping area represents the amount of predictability between DNA Biomed time series from 29th of February 2024 to 13th of July 2024 and 13th of July 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DNA Biomed Solns price movement. The serial correlation of -0.07 indicates that barely 7.0% of current DNA Biomed price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.07 | |
| Spearman Rank Test | -0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 86.55 |
DNA Biomed Solns lagged returns against current returns
Autocorrelation, which is DNA Biomed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting DNA Biomed's stock expected returns. We can calculate the autocorrelation of DNA Biomed returns to help us make a trade decision. For example, suppose you find that DNA Biomed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
DNA Biomed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If DNA Biomed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if DNA Biomed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in DNA Biomed stock over time.
Current vs Lagged Prices |
| Timeline |
DNA Biomed Lagged Returns
When evaluating DNA Biomed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of DNA Biomed stock have on its future price. DNA Biomed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, DNA Biomed autocorrelation shows the relationship between DNA Biomed stock current value and its past values and can show if there is a momentum factor associated with investing in DNA Biomed Solns.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DNA Stock
DNA Biomed financial ratios help investors to determine whether DNA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DNA with respect to the benefits of owning DNA Biomed security.